Teleflex Incorporated

$ 135.75

3.04%

09 Jun - close price

  • Market Cap 5,832,158,000 USD
  • Current Price $ 135.75
  • High / Low $ 136.15 / 131.90
  • Stock P/E 1882.00
  • Book Value 69.68
  • EPS 0.07
  • Next Earning Report 2026-07-30
  • Dividend Per Share $1.36
  • Dividend Yield 1.05 %
  • Next Dividend Date 2026-06-30
  • ROA 0.02 %
  • ROE N/A %
  • 52 Week High 139.31
  • 52 Week Low 99.63

About

Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is an American provider of specialty medical devices for a range of procedures in critical care and surgery.

Analyst Target Price

$143.67

Quarterly Earnings

Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Reported Date 2026-05-072026-02-262025-11-062025-07-312025-05-012025-02-272024-10-312024-08-012024-05-022024-02-222023-11-022023-08-03
Reported EPS 1.391.933.673.732.913.893.493.423.213.383.643.41
Estimated EPS 1.213.793.383.372.88423.883.393.333.073.263.273.21
Surprise 0.18-1.860.290.360.02580.010.10.090.140.120.370.2
Surprise Percentage 14.876%-49.0765%8.5799%10.6825%0.8945%0.2577%2.9499%2.7027%4.5603%3.681%11.315%6.2305%

Next Quarterly Earnings

Jun 2026
Reported Date 2026-07-30
Fiscal Date Ending 2026-06-30
Estimated EPS 1.29
Currency USD

Previous Dividend Records

Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Payment Date 2026-06-302026-03-312025-12-152025-09-152025-06-162025-03-172024-12-162024-09-162024-06-142024-03-15
Amount $0.34$0.34$0.34$0.34$0.34$0.34$0.34$0.34$0.34$0.34

Next Dividend Records

Dividend per share (year): $1.36
Dividend Yield 1.05%
Next Dividend Date 2026-06-30
Ex-Dividend Date 2026-05-22

Recent News: TFX

...
Teleflex unveils four-year data for Freesolve medical scaffold

2026-06-09 17:10:30

Teleflex announced positive four-year follow-up data from its First-in-Human BIOMAG-I clinical trial for its Freesolve Resorbable Magnesium Scaffold. The data, presented at the EuroPCR conference, showed no new cardiac-related events between two and four years, with a zero percent rate for critical safety metrics like cardiac death and scaffold thrombosis. This indicates long-term safety and performance stability, supporting Teleflex's ongoing and planned clinical trials for its bioresorbable magnesium platform.

4-year study sees zero cardiac deaths with dissolving magnesium scaffold

2026-06-09 10:10:30

Teleflex announced four-year follow-up data from its BIOMAGâ„¢-I Clinical Study, demonstrating the long-term safety and sustained performance of its Freesolveâ„¢ Resorbable Magnesium Scaffold (RMS). The study, involving 116 patients, reported no cardiac deaths, target-vessel myocardial infarctions, or scaffold thromboses over the four-year period, with a low target lesion failure rate of 3.5%. These positive results support the Freesolveâ„¢ RMS as a promising treatment option, particularly for patients seeking alternatives to permanent implants, and lay the groundwork for upcoming randomized controlled trials.

...
Teleflex Inc. stock outperforms competitors on strong trading day

2026-06-08 17:30:00

Teleflex Inc. (TFX) shares rose 1.46% to $131.74 on Monday, despite a mixed trading session for the broader market. The S&P 500 Index saw a slight increase, while the Dow Jones Industrial Average experienced a slight fall. Teleflex Inc. closed 5.68% below its 52-week high.

Piper Sandler Initiates Teleflex(TFX.US) With Buy Rating, Announces Target Price $160

2026-06-08 11:08:54

Piper Sandler has initiated coverage on Teleflex (TFX.US) with a Buy rating. The firm has set a price target of $160 for the medical technology company's stock. This initiation indicates a positive outlook from Piper Sandler on Teleflex's future performance.

...
Piper Sandler upgrades Teleflex stock rating on synergy potential By Investing.com

2026-06-08 10:08:54

Piper Sandler upgraded Teleflex Inc. (NYSE:TFX) to Overweight from Neutral, raising its price target to $160 due to potential Biotronik synergies, future estimate revisions, and possible activist involvement. The company demonstrates financial stability with 50 consecutive years of dividend payments and strong revenue growth. While acknowledging integration and inflationary risks, Piper Sandler believes the rewards outweigh the downsides, predicting improved performance and an increased multiple for the stock.

...
Teleflex Inc. stock underperforms Friday when compared to competitors

2026-06-05 17:30:00

Teleflex Inc. (TFX) stock fell 1.72% on Friday, closing at $129.84, underperforming the broader market. This drop occurred during a challenging trading session where the S&P 500 Index decreased by 2.64% and the Dow Jones Industrial Average fell by 1.35%. The stock's decline ended a two-day winning streak.

Iscriviti alla nostra newsletter

Email Subscription Form


Resta aggiornato. Ricevi tutti i nuovi articoli e le notizie ogni settimana.
banner startinvesting

Questo si chiuderà in 0 secondi